Skip to main content
. 2022 Oct 3;13:960263. doi: 10.3389/fgene.2022.960263

FIGURE 2.

FIGURE 2

Mechanisms of regulation of HDACs and signaling pathways associated with resistance to therapies in lung cancer. Epigenetic therapies with HDAC inhibitors regulate different signaling pathways, proteasome activity, and transcriptional repression of genes involved in the cancer hallmarks of lung cancer. Created with Biorender.com.

Inline graphicPhosphorylation Inline graphicAcetylation Inline graphicUp-regulation Inline graphicActivation Inline graphicInhibition Inline graphicMechanism promoted by treatments